3rd Annual Resident and Fellow - Rochester, NY...No standard therapy other than supportive care...

1

Transcript of 3rd Annual Resident and Fellow - Rochester, NY...No standard therapy other than supportive care...

Page 1: 3rd Annual Resident and Fellow - Rochester, NY...No standard therapy other than supportive care Dextromethorphan (DM), NMDA antagonist o In study of 18 patients with sudden onset of

Dextromethorphan abuse: Clinical effects and managementaccurateclinic.com/wp-content/uploads/2016/05/... · 2016-09-02 · Dextromethorphan abuse: Clinical effects and management

Dextromethorphan abuse: Clinical effects and managementaccurateclinic.com/wp-content/uploads/2016/05/... · 2016-09-02 · Dextromethorphan abuse: Clinical effects and management

Dextromethorphan Pre-Review Report

Dextromethorphan Pre-Review Report

DEXTROMETHORPHAN HYDROBROMIDE 10MG/5ML ORAL … · Dextromethorphan Hydrobromide 10mg/5ml Oral ... stable product containing the active ingredient dextromethorphan hydrobromide 10mg/5ml.

DEXTROMETHORPHAN HYDROBROMIDE 10MG/5ML ORAL … · Dextromethorphan Hydrobromide 10mg/5ml Oral ... stable product containing the active ingredient dextromethorphan hydrobromide 10mg/5ml.

Characterising seizures in anti-NMDA-receptor encephalitis ...karl/Characterising seizures in anti-NMDA-receptor...Characterising seizures in anti-NMDA-receptor encephalitis with dynamic

Characterising seizures in anti-NMDA-receptor encephalitis ...karl/Characterising seizures in anti-NMDA-receptor...Characterising seizures in anti-NMDA-receptor encephalitis with dynamic

The NMDA Receptor Antagonist D-2=amino .... Davis, S. P. Butcher, and Ft. G. M. Morris Department of Pharmacology, University of Edinburgh Medical School, Edinburgh EH8 9JZ, Scotland

The NMDA Receptor Antagonist D-2=amino .... Davis, S. P. Butcher, and Ft. G. M. Morris Department of Pharmacology, University of Edinburgh Medical School, Edinburgh EH8 9JZ, Scotland

A COMPETITIVE NMDA RECEPTOR ANTAGONIST POTENTIATES …libres.uncg.edu/ir/uncw/f/millerl2005-1.pdf · However, little is known about side effects related to NMDA antagonist-opioid

A COMPETITIVE NMDA RECEPTOR ANTAGONIST POTENTIATES …libres.uncg.edu/ir/uncw/f/millerl2005-1.pdf · However, little is known about side effects related to NMDA antagonist-opioid

PowerPoint Presentationpemplaybook.org/wp-content/uploads/2016/01/Intranasal-meds-PED... · Ketamine •NMDA receptor antagonist, related to PCP

PowerPoint Presentationpemplaybook.org/wp-content/uploads/2016/01/Intranasal-meds-PED... · Ketamine •NMDA receptor antagonist, related to PCP

Intra-cerebellar infusion of NMDA receptor antagonist AP5 disrupts ...

Intra-cerebellar infusion of NMDA receptor antagonist AP5 disrupts ...

Review Article Early Use of the NMDA Receptor …downloads.hindawi.com/journals/ccrp/2015/831260.pdfReview Article Early Use of the NMDA Receptor Antagonist Ketamine in Refractory

Review Article Early Use of the NMDA Receptor …downloads.hindawi.com/journals/ccrp/2015/831260.pdfReview Article Early Use of the NMDA Receptor Antagonist Ketamine in Refractory

Dual Kainate Nmda

Dual Kainate Nmda

mGluR5 Antagonist Induced Psychoactive Properties: MTEP ...jpet.aspetjournals.org/.../28/jpet.113.211185.full.pdf · antagonists MPEP and SIB-1893 can inhibit NMDA receptor mediated

mGluR5 Antagonist Induced Psychoactive Properties: MTEP ...jpet.aspetjournals.org/.../28/jpet.113.211185.full.pdf · antagonists MPEP and SIB-1893 can inhibit NMDA receptor mediated

DXM/ DM Dextromethorphan

DXM/ DM Dextromethorphan

AstraZeneca - LHVZD0947 K+ channel opener II Overactive bladder 300m-1,000m AZD8129 5HT(1beta) antagonist II Anxiety/depression 1bn-2bn AZD4282 NMDA antagonist I Neuropathic pain Oncology

AstraZeneca - LHVZD0947 K+ channel opener II Overactive bladder 300m-1,000m AZD8129 5HT(1beta) antagonist II Anxiety/depression 1bn-2bn AZD4282 NMDA antagonist I Neuropathic pain Oncology

Nuedexta, INN-dextromethorphan/quinidine

Nuedexta, INN-dextromethorphan/quinidine

Alzheimer’s Agents Review - Nevada · 12/11/2008  · NMDA receptor antagonist ... The discovery of vast cholinergic cell loss led to the cholinergic hypothesis and the development

Alzheimer’s Agents Review - Nevada · 12/11/2008  · NMDA receptor antagonist ... The discovery of vast cholinergic cell loss led to the cholinergic hypothesis and the development

Functional NMDA receptor-based target engagement ...€¦ · Moghaddam et al., Science. 281:1349-52, 1998 • Treatment with an NMDAR antagonist ... NYU, UAB, UCLA) (100 total subjects

Functional NMDA receptor-based target engagement ...€¦ · Moghaddam et al., Science. 281:1349-52, 1998 • Treatment with an NMDAR antagonist ... NYU, UAB, UCLA) (100 total subjects

SCANDINAVIAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY€¦ · introduction of selective serotonin reuptake inhibitors in the 1980's. The N-methyl-D-aspartate (NMDA) receptor antagonist

SCANDINAVIAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY€¦ · introduction of selective serotonin reuptake inhibitors in the 1980's. The N-methyl-D-aspartate (NMDA) receptor antagonist

DEXTROMETHORPHAN AND ITS METABOLITES IN RAT BONE …

DEXTROMETHORPHAN AND ITS METABOLITES IN RAT BONE …

Effects of Memantine, an NMDA Antagonist, on Metabolic … · 2016. 6. 29. · effect of glutamate NMDA receptors in the nucleus ac-cumbens by the chronic administration of memantine

Effects of Memantine, an NMDA Antagonist, on Metabolic … · 2016. 6. 29. · effect of glutamate NMDA receptors in the nucleus ac-cumbens by the chronic administration of memantine

Selective impairment of learning and blockade of long-term potentiantion by an NMDA receptor antagonist, AP5 Presentation by: David Alexanian Ellen Almirol.

Selective impairment of learning and blockade of long-term potentiantion by an NMDA receptor antagonist, AP5 Presentation by: David Alexanian Ellen Almirol.